Jupiter Life Line Hospitals Ltd (NSE: JLHL, BSE: 543980) is a Mumbai, Maharashtra-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹8,099 Cr, it ranks #662 by market cap among the 6,137 Indian listed companies on FinBizNet, and #13 of 42 in Hospitals and Healthcare Centers. At ₹244.00 (as of 25 Oct 2026), the share price is 28.2% below its 52-week high of ₹340.00 and 4.5% above its 52-week low of ₹233.40. The share price is down 20.3% over one year and down 24.5% over three months.
| Current Price | ₹244.00 |
|---|---|
| Market Cap | ₹8,099 Cr |
| NSE Symbol | JLHL |
| BSE Code | 543980 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 41.1 |
| Return on Equity | 13.73% |
| Return on Assets | 7.44% |
| 52-Week Range | ₹233.40 – ₹340.00 |
| 1-Year Price Change | -20.3% |
| 3-Month Price Change | -24.5% |
| Beta (1Y) | 0.11 |
| Dividend Yield | 0.08% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.jupiterhospital.com |
| Revenue | ₹457 Cr |
|---|---|
| Net Profit | ₹56 Cr |
| Net Margin | 12.3% |
| EPS (Basic) | ₹1.72 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, TAVI/TAVR, and urology. It also operates hotel under the Fortune Park Lake City Hotel name in Thane. The company was incorporated in 2002 and is based in Mumbai, India.
1. Healthcare Services-This segment provides healthcare services. 2. NA-NA 3. NA-NA 4. NA-NA
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Jupiter Life Line Hospitals Ltd | ₹8,099 Cr | 41.1 | 13.73% | ₹457 Cr | -20.3% |
Listed by market capitalisation. Ratios are shown for context only.
Jupiter Life Line Hospitals Ltd is trading at ₹244.00, with a market capitalisation of ₹8,099 Cr.
Jupiter Life Line Hospitals Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Jupiter Life Line Hospitals Ltd has a P/E of 41.1 and a return on equity of 13.73%.
Jupiter Life Line Hospitals Ltd is listed on the NSE under the symbol JLHL and on the BSE under the scrip code 543980.
Jupiter Life Line Hospitals Ltd's share price is down 20.3% over one year and down 24.5% over three months. Its 52-week range is ₹233.40 to ₹340.00.
In Q2 FY27, Jupiter Life Line Hospitals Ltd reported revenue of ₹457 Cr and net profit of ₹56 Cr, with basic EPS of ₹1.72 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.